One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer product conglomerate.

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

Shareholders of Kimberly-Clark will own about 54% of the combined company. Two years ago, Johnson & Johnson spun off its ...

The announcement comes weeks after President Trump made claims linking Tylenol to autism in pregnant women's unborn babies, ...

Summit, NJ-based Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year.

The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to autism.

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...

Kimberly-Clark said Monday it would acquire Kenvue for more than $40 billion in cash and stock, creating a consumer ...

Kimberly-Clark on Monday said it is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, combining ...